Literature DB >> 27813288

The pathology of the foreign body reaction against biomaterials.

R Klopfleisch1, F Jung2.   

Abstract

The healing process after implantation of biomaterials involves the interaction of many contributing factors. Besides their in vivo functionality, biomaterials also require characteristics that allow their integration into the designated tissue without eliciting an overshooting foreign body reaction (FBR). The targeted design of biomaterials with these features, thus, needs understanding of the molecular mechanisms of the FBR. Much effort has been put into research on the interaction of engineered materials and the host tissue. This elucidated many aspects of the five FBR phases, that is protein adsorption, acute inflammation, chronic inflammation, foreign body giant cell formation, and fibrous capsule formation. However, in practice, it is still difficult to predict the response against a newly designed biomaterial purely based on the knowledge of its physical-chemical surface features. This insufficient knowledge leads to a high number of factors potentially influencing the FBR, which have to be analyzed in complex animal experiments including appropriate data-based sample sizes. This review is focused on the current knowledge on the general mechanisms of the FBR against biomaterials and the influence of biomaterial surface topography and chemical and physical features on the quality and quantity of the reaction.
© 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 927-940, 2017. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  biocompatibility; biomaterials; fibrosis; foreign body giant cells; foreign body reaction; macrophages

Mesh:

Substances:

Year:  2016        PMID: 27813288     DOI: 10.1002/jbm.a.35958

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  69 in total

Review 1.  Advances in Biomaterials for Drug Delivery.

Authors:  Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal:  Adv Mater       Date:  2018-05-07       Impact factor: 30.849

2.  Tunable Elastomers with an Antithrombotic Component for Cardiovascular Applications.

Authors:  Alexander M Stahl; Yunzhi Peter Yang
Journal:  Adv Healthc Mater       Date:  2018-05-31       Impact factor: 9.933

Review 3.  Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.

Authors:  William R Lykins; Ellen Luecke; Daniel Johengen; Ariane van der Straten; Tejal A Desai
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

Review 4.  Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.

Authors:  Bryan N Brown; Martin J Haschak; Samuel T Lopresti; Elizabeth C Stahl
Journal:  Semin Immunol       Date:  2017-05-20       Impact factor: 11.130

5.  A Foreign Body Response-on-a-Chip Platform.

Authors:  Fatemeh Sharifi; Su Su Htwe; Martina Righi; Hua Liu; Anna Pietralunga; Ozlem Yesil-Celiktas; Sushila Maharjan; Byung-Hyun Cha; Su Ryon Shin; Mehmet Remzi Dokmeci; Nihal Engin Vrana; Amir M Ghaemmaghami; Ali Khademhosseini; Yu Shrike Zhang
Journal:  Adv Healthc Mater       Date:  2019-01-29       Impact factor: 9.933

Review 6.  Sequential drug delivery to modulate macrophage behavior and enhance implant integration.

Authors:  Erin M O'Brien; Gregory E Risser; Kara L Spiller
Journal:  Adv Drug Deliv Rev       Date:  2019-05-16       Impact factor: 15.470

7.  Non-healing wounds: Can it take different diagnosis?

Authors:  Hasan Calis; Serkan Sengul; Yilmaz Guler; Zulfikar Karabulut
Journal:  Int Wound J       Date:  2019-12-29       Impact factor: 3.315

8.  Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.

Authors:  Ichiyo Shibahara; Mitsuto Hanihara; Takashi Watanabe; Mitsuru Dan; Sumito Sato; Hiroki Kuroda; Akinori Inamura; Madoka Inukai; Atsuko Hara; Yoshie Yasui; Toshihiro Kumabe
Journal:  J Neurooncol       Date:  2018-02-21       Impact factor: 4.130

9.  Mesh induced fibrosis: The protective role of T regulatory cells.

Authors:  Amanda M Artsen; Matthew Rytel; Rui Liang; Gabrielle E King; Leslie Meyn; Steven D Abramowitch; Pamela A Moalli
Journal:  Acta Biomater       Date:  2019-07-19       Impact factor: 8.947

10.  Harnessing the Digital Exhaust: Incorporating wellness into the pharma model.

Authors:  Justin M Wright; Graham B Jones
Journal:  Digit Biomark       Date:  2018-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.